VYMSSYJRDNRMBE-QCDSWUKFSA-N
C31H29F4N7O3S — CID 142455872
Data last refreshed: (MolForge compound catalog, from PubChem)
About VYMSSYJRDNRMBE-QCDSWUKFSA-N
VYMSSYJRDNRMBE-QCDSWUKFSA-N (PubChem CID 142455872) has the molecular formula C31H29F4N7O3S and a molecular weight of 655.68 g/mol. Its IUPAC name is N-[(4aS,6S)-1-(4-fluorophenyl)-4a-[5-(trifluoromethyl)pyridine-2-carbonyl]-5,6,7,8-tetrahydro-4H-benzo[f]indazol-6-yl]-2-cyclopropyl-N-ethyltriazole-4-sulfonamide.
Molecular Properties
| Compound Name | VYMSSYJRDNRMBE-QCDSWUKFSA-N |
|---|---|
| PubChem CID | 142455872 |
| Molecular Formula | C31H29F4N7O3S |
| Molecular Weight | 655.68 g/mol |
| Exact Mass | 655.20 |
| IUPAC Name | N-[(4aS,6S)-1-(4-fluorophenyl)-4a-[5-(trifluoromethyl)pyridine-2-carbonyl]-5,6,7,8-tetrahydro-4H-benzo[f]indazol-6-yl]-2-cyclopropyl-N-ethyltriazole-4-sulfonamide |
| SMILES | CCN([C@H]1CCC2=Cc3c(cnn3-c3ccc(F)cc3)C[C@]2(C(=O)c2ccc(C(F)(F)F)cn2)C1)S(=O)(=O)c1cnn(C2CC2)n1 |
| InChI | InChI=1S/C31H29F4N7O3S/c1-2-40(46(44,45)28-18-38-42(39-28)24-10-11-24)25-7-3-20-13-27-19(16-37-41(27)23-8-5-22(32)6-9-23)14-30(20,15-25)29(43)26-12-4-21(17-36-26)31(33,34)35/h4-6,8-9,12-13,16-18,24-25H,2-3,7,10-11,14-15H2,1H3/t25-,30-/m0/s1 |
| InChIKey | VYMSSYJRDNRMBE-QCDSWUKFSA-N |
| XLogP | 5.42 |
| TPSA | 115.87 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 655.68 |
| LogP ≤ 5 | 5.42 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142455872 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.